How can improper storage affect lurbinectedin's effectiveness?

Improper storage can compromise lurbinectedin’s effectiveness mainly by causing chemical degradation or physical instability. That can lead to lower active drug exposure at the tumor site and more variable, unpredictable outcomes. It can also create or release impurities that could increase toxicity. Here are the key ways storage or handling problems can affect potency and safety:

- Temperature excursions
- Excessive heat or freezing can degrade lurbinectedin and reduce the amount of intact drug available for infusion.
- Repeated temperature cycling can worsen this degradation.

- Light exposure
- Light can trigger photochemical degradation, reducing potency and potentially forming harmful byproducts.

- Moisture and packaging integrity
- For a lyophilized powder, moisture ingress can affect stability during storage.
- Damaged or open packaging can lead to contamination or accelerated degradation.

- Reconstitution and dilution
- Reconstituting and diluting the drug outside recommended conditions (incorrect diluent, wrong concentration, or improper timing) can reduce potency and change safety profile.
- Solutions that are cloudy, discolored, or contain visible particulates should not be used.

- Time after opening/reconstitution
- Even under proper storage, there are usually strict windows for using reconstituted or diluted solutions. Using beyond those windows can mean the drug is less potent or unsafe.

- Visual or physical changes
- Precipitation, discoloration, or turbidity can indicate instability. Do not use such products.

- Contamination risk
- Improper handling can contaminate the product, making it unsafe and less effective when administered.

To minimize risk and preserve effectiveness:
- Store exactly as specified on the product labeling (including whether it should be refrigerated or kept at room temperature and protected from light).
- Keep vials in their original packaging and protect from light.
- Do not freeze if the label says not to; avoid repeated temperature changes.
- Use reconstituted or diluted solutions within the time frames stated in the labeling.
- Inspect the product for any changes in appearance before use.
- Follow aseptic technique and institutional guidelines when handling cytotoxic agents.

If you’d like, tell me the exact storage conditions you’re using (e.g., whether it’s unreconstituted powder vs. reconstituted solution, temperatures, and time frames). I can help interpret whether those conditions are appropriate or what to do next. For precise, up-to-date storage and handling instructions, refer to the official prescribing information for lurbinectedin (Zepzelca) or your institution’s guidelines.